3 table dc
keisha345
2 years ago
20
files (1)3tabledrc.docx
3tabledrc.docx
|
Drug name |
Indication Target symptoms: state if positive or negative effect Potency (if noted. receptor occupancy if noted ) Neurotransmitter(s) affected |
Half-life (T1/2), metabolism (CYP 450 enzyme) |
Notable side effects (associate to pathway or NT) |
|
Typical antipsychotics (conventional) |
|||
|
Haloperidol |
|
|
|
|
Thioridazine |
|
|
|
|
Thiothixene |
|
|
|
|
Fluphenazine |
|
|
|
|
Mesoridazine |
|
|
|
|
Chlorpromazine |
|
|
|
|
Atypical antipsychotics (2nd generation) |
|||
|
Pines |
|
|
|
|
Olanzapine |
|
|
|
|
Quetiapine |
|
|
|
|
Asenapine |
|
|
|
|
Clozapine |
|
|
|
|
Dones |
|
|
|
|
Risperidone |
|
|
|
|
Paliperidone |
|
|
|
|
Ziprasidone |
|
|
|
|
Iloperidne |
|
|
|
|
Lurasidone |
|
|
|
|
Two Pips and a Rip |
|
|
|
|
Aripiprazole |
|
|
|
|
Brexpiprazole |
|
|
|
|
Cariprazine |
|
|
|
1. For each medication listed, complete the following:
a. Provide indication, target symptoms, potency, and affected neurotransmitters.
b. Include half-life and CYP 450 enzyme information.
c. List notable side effects.
d. Link notable side effects to the associated pathway or neurotransmitter.
Provide 7th edition apa references within 5 years. 2 references provided below.
Stahl, S. M. (2021a). Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 7th ed. Chamberlain University Press.
Stahl, S. M. (2021b). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. In Google Books. Cambridge University Press.
